Tagged: Sandoz guilty plea

Taro, Sandoz and Apotex Pay $447.2 Million to Settle False Claims Act Liability for Price-Fixing of Generic Drugs

The healthcare industry faces cascading risks – one risk flows to another with compounding financial results.  Three generic drug companies just experienced this cascading liability.  As part of the Justice Department Antitrust Division’s investigation of the generic drug industry, Taro, Sandoz and Apotex settled criminal antitrust cases by entering into a deferred prosecution agreement, paying a financial settlement and agreeing to cooperate with the ongoing...

DOJ Catches Big Fish in Generic Pharmaceutical Criminal Antitrust Investigation

DOJ Catches Big Fish in Generic Pharmaceutical Criminal Antitrust Investigation

The Justice Department’s Antitrust Division announced a major guilty plea with Sandoz, Inc., in its expanding criminal investigation of the generic pharmaceutical industry.  DOJ has been pursuing this investigation for several years with some progress, but the Sandoz guilty plea is a major accomplishment in the investigation.  Sandoz agreed to pay $195 million in exchange for a three-year deferred purchase agreement (“DPA”).  DOJ filed a...